{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:17:27Z","timestamp":1793319447825,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Hyperhomocysteinemia and the metabolic syndrome are established cardiovascular risk factors and are frequently associated with hypertension. The relationship of plasma homocysteine (Hcy) with the metabolic syndrome and insulin resistance, however, is debated and studies in hypertensive patients are limited. In this study, we have investigated the association of Hcy with the metabolic syndrome and cerebro- cardiovascular events in hypertension.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>In 562 essential hypertensive patients who underwent accurate assessment of fasting and postload glucose metabolism, insulin sensitivity, and renal function, we measured plasma levels of Hcy, vitamin B12, folate, and fibrinogen and assessed the prevalence of the metabolic syndrome and of coronary heart and cerebrovascular disease (CVD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Patients with the metabolic syndrome had significantly higher plasma Hcy levels. After correction for covariates, increasing Hcy levels were associated with an increasing prevalence of the metabolic syndrome, coronary heart disease, and CVD. Plasma Hcy was directly correlated with age, waist circumference, fasting glucose, triglyceride, uric acid, and fibrinogen levels, and homeostatic model assessment index and inversely with creatinine clearance and high-density lipoprotein cholesterol, vitamin B12, and folate levels. Logistic regression analysis showed an independent association of Hcy levels with age, male gender, vitamin B12 and folate levels, and the metabolic syndrome. Logistic regression indicated also an independent association of Hcy with cerebro-cardiovascular disease that was independent of the metabolic syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Elevated plasma Hcy is associated with the metabolic syndrome in hypertensive patients. Prevalence of events increases with increasing plasma Hcy levels suggesting a contribution of Hcy to cerebro-cardiovascular diseases in these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpu248","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T21:58:41Z","timestamp":1418421521000},"page":"943-950","source":"Crossref","is-referenced-by-count":77,"title":["Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients"],"prefix":"10.1093","volume":"28","author":[{"given":"Cristiana","family":"Catena","sequence":"first","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine 1 \u00a0 , Udine , .","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Colussi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine 1 \u00a0 , Udine , .","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Nait","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine 1 \u00a0 , Udine , .","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frine","family":"Capobianco","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine 1 \u00a0 , Udine , .","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A.","family":"Sechi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine 1 \u00a0 , Udine , .","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"2025090108211548000_CIT0001","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","article-title":"Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men","volume":"346","author":"Perry","year":"1995","journal-title":"Lancet"},{"key":"2025090108211548000_CIT0002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"2025090108211548000_CIT0003","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Arch Intern Med"},{"key":"2025090108211548000_CIT0004","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev.nutr.24.012003.132418","article-title":"Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine","volume":"24","author":"Stipanuk","year":"2004","journal-title":"Annu Rev Nutr"},{"key":"2025090108211548000_CIT0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2891-3-4","article-title":"Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation","volume":"3","author":"Hayden","year":"2004","journal-title":"Nutr J"},{"key":"2025090108211548000_CIT0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/07853899209166997","article-title":"Abdominal obesity and the metabolic syndrome","volume":"24","author":"Bj\u00f6rntorp","year":"1992","journal-title":"Ann Med"},{"key":"2025090108211548000_CIT0007","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCULATIONAHA.106.671057","article-title":"Metabolic syndrome","volume":"115","author":"Opie","year":"2007","journal-title":"Circulation"},{"key":"2025090108211548000_CIT0008","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025090108211548000_CIT0009","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/meta.2000.6256","article-title":"Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat","volume":"49","author":"Fonseca","year":"2000","journal-title":"Metabolism"},{"key":"2025090108211548000_CIT0010","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0026-0495(03)00262-2","article-title":"Hyperhomocysteinemia as a component of syndrome X","volume":"52","author":"Oron-Herman","year":"2003","journal-title":"Metabolism"},{"key":"2025090108211548000_CIT0011","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00380-004-0822-4","article-title":"Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome","volume":"20","author":"Guven","year":"2005","journal-title":"Heart Vessels"},{"key":"2025090108211548000_CIT0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/hrt.2006.093971","article-title":"Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome","volume":"93","author":"Hajer","year":"2007","journal-title":"Heart"},{"key":"2025090108211548000_CIT0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/met.2006.4.185","article-title":"Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome?","volume":"4","author":"Garcin","year":"2006","journal-title":"Metab Syndr Relat Disord"},{"key":"2025090108211548000_CIT0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0895-7061(99)00138-7","article-title":"Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects","volume":"13","author":"Sheu","year":"2000","journal-title":"Am J Hypertens"},{"key":"2025090108211548000_CIT0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0895-7061(02)02984-9","article-title":"Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins","volume":"15","author":"Kahleov\u00e1","year":"2002","journal-title":"Am J Hypertens"},{"key":"2025090108211548000_CIT0016","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.jhh.1001986","article-title":"The relationship between the levels of plasma total homocysteine and insulin resistance in uncomplicated mild-to-moderate primary hypertension","volume":"20","author":"Ustundag","year":"2006","journal-title":"J Hum Hypertens"},{"key":"2025090108211548000_CIT0017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0002-9343(00)00567-2","article-title":"Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance","volume":"109","author":"Catena","year":"2000","journal-title":"Am J Med"},{"key":"2025090108211548000_CIT0018","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"2025090108211548000_CIT0019","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0037-1614068","article-title":"Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events","volume":"84","author":"Sechi","year":"2000","journal-title":"Thromb Haemost"},{"key":"2025090108211548000_CIT0020","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"2025090108211548000_CIT0021","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0026-0495(92)90019-7","article-title":"Insulin hypersecretion: a distinctive feature between essential and secondary hypertension","volume":"41","author":"Sechi","year":"1992","journal-title":"Metabolism"},{"key":"2025090108211548000_CIT0022","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.alc.0000183004.28587.23","article-title":"Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal","volume":"29","author":"Soardo","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"2025090108211548000_CIT0023","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00004872-200302000-00018","article-title":"Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage","volume":"21","author":"Catena","year":"2003","journal-title":"J Hypertens"},{"key":"2025090108211548000_CIT0024","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2215\/CJN.00050107","article-title":"Relationships of plasma renin levels with renal function in patients with primary aldosteronism","volume":"2","author":"Catena","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025090108211548000_CIT0025","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ajh.2008.293","article-title":"Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage","volume":"21","author":"Sechi","year":"2008","journal-title":"Am J Hypertens"},{"key":"2025090108211548000_CIT0026","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ajh\/hpt114","article-title":"Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients","volume":"26","author":"Catena","year":"2013","journal-title":"Am J Hypertens"},{"key":"2025090108211548000_CIT0027","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1507\/endocrj.K07E-018","article-title":"Relationship between metabolic syndrome categorized by newly recommended by International Diabetes Federation criteria with plasma homocysteine concentration","volume":"54","author":"Rhee","year":"2007","journal-title":"Endocr J"},{"key":"2025090108211548000_CIT0028","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF03346476","article-title":"The metabolic syndrome is not associated with homocysteinemia: the Persian Gulf Healthy Heart Study","volume":"32","author":"Nabipour","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"2025090108211548000_CIT0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/CH-2010-1366","article-title":"Homocysteine levels and the metabolic syndrome in a Mediterranean population: a case-control study","volume":"47","author":"Vay\u00e1","year":"2011","journal-title":"Clin Hemorheol Microcirc"},{"key":"2025090108211548000_CIT0030","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.2169\/internalmedicine.51.8475","article-title":"The relationship between metabolic syndrome, cardiometabolic risk factors and inflammatory markers in a Tehranian population: the Tehran Lipid and Glucose Study","volume":"51","author":"Zarkesh","year":"2012","journal-title":"Intern Med"},{"key":"2025090108211548000_CIT0031","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/met.2008.0037","article-title":"Is plasma homocysteine level associated with metabolic syndrome components in adolescents?","volume":"7","author":"Budak","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"2025090108211548000_CIT0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/CH-2012-1544","article-title":"Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance","volume":"52","author":"Vay\u00e1","year":"2012","journal-title":"Clin Hemorheol Microcirc"},{"key":"2025090108211548000_CIT0033","first-page":"999","article-title":"Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease","volume":"3","author":"Bellia","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"2025090108211548000_CIT0034","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/diacare.24.8.1403","article-title":"Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study","volume":"24","author":"Meigs","year":"2001","journal-title":"Diabetes Care"},{"key":"2025090108211548000_CIT0035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2006.03.010","article-title":"Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project","volume":"55","author":"Bj\u00f6rck","year":"2006","journal-title":"Metabolism"},{"key":"2025090108211548000_CIT0036","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1447-0756.2007.00699.x","article-title":"The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome","volume":"34","author":"Yilmaz","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"2025090108211548000_CIT0037","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psychres.2010.11.021","article-title":"Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics","volume":"189","author":"Vuksan-\u0106usa","year":"2011","journal-title":"Psychiatry Res"},{"key":"2025090108211548000_CIT0038","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9150(99)00132-X","article-title":"Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal","volume":"146","author":"Abbasi","year":"1999","journal-title":"Atherosclerosis"},{"key":"2025090108211548000_CIT0039","first-page":"719","article-title":"Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men","volume":"86","author":"Godsland","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2025090108211548000_CIT0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-2006-924073","article-title":"Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance","volume":"114","author":"Sch\u00e4fer","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/28\/7\/943\/64171061\/ajh_28_7_943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/28\/7\/943\/64171061\/ajh_28_7_943.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:21:26Z","timestamp":1756729286000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/28\/7\/943\/2743393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,12,12]]},"published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpu248","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,7,1]]},"published":{"date-parts":[[2014,12,12]]}}}